How to develop a meaningful radiomic signature for clinical use in oncologic patients

156Citations
Citations of this article
195Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

During the last decade, there is an increasing usage of quantitative methods in Radiology in an effort to reduce the diagnostic variability associated with a subjective manner of radiological interpretation. Combined approaches where visual assessment made by the radiologist is augmented by quantitative imaging biomarkers are gaining attention. Advances in machine learning resulted in the rise of radiomics that is a new methodology referring to the extraction of quantitative information from medical images. Radiomics are based on the development of computational models, referred to as "Radiomic Signatures", trying to address either unmet clinical needs, mostly in the field of oncologic imaging, or to compare radiomics performance with that of radiologists. However, to explore this new technology, initial publications did not consider best practices in the field of machine learning resulting in publications with questionable clinical value. In this paper, our effort was concentrated on how to avoid methodological mistakes and consider critical issues in the workflow of the development of clinically meaningful radiomic signatures.

Cite

CITATION STYLE

APA

Papanikolaou, N., Matos, C., & Koh, D. M. (2020, May 1). How to develop a meaningful radiomic signature for clinical use in oncologic patients. Cancer Imaging. BioMed Central Ltd. https://doi.org/10.1186/s40644-020-00311-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free